Connect with us

Hi, what are you looking for?

Business

Blair William & Co. Reduces Stake in IDEX Corporation by Nearly 10%

Blair William & Co. IL has decreased its holding in IDEX Corporation (NYSE:IEX) by 9.6% during the second quarter of 2024, according to its recent Form 13F filing with the Securities and Exchange Commission (SEC). Following the sale of 394 shares, the firm now possesses 3,697 shares of the industrial products company, valued at approximately $649,000.

This reduction in stake comes amidst notable changes among other institutional investors in IDEX. For instance, Thurston Springer Miller Herd & Titak Inc. increased its investment by an impressive 257.5%, now holding 143 shares valued at $25,000 after acquiring an additional 103 shares. Similarly, American National Bank & Trust has entered a new position in IDEX valued at around $25,000, while Steph & Co. has made a new investment approximated at $42,000. SVB Wealth LLC also acquired a new position earlier this year worth about $56,000.

In total, institutional investors and hedge funds own 97.96% of IDEX’s stock, reflecting strong interest from the investment community.

IDEX Stock Performance and Financial Highlights

On October 20, 2024, shares of IDEX opened at $164.95. Over the past year, the stock has fluctuated between a low of $153.36 and a high of $238.22. IDEX Corporation has a market capitalization of $12.42 billion, with a price-to-earnings ratio of 26.65 and a PEG ratio of 1.72. Its current ratio stands at 3.05, with a quick ratio of 2.13 and a debt-to-equity ratio of 0.46.

In its latest earnings report, released on December 16, 2023, IDEX posted earnings per share (EPS) of $1.79 for the quarter, achieving a net margin of 14.05% and a return on equity of 15.16%. The company recorded revenue of $712.00 million for the quarter, and analysts predict an EPS of $8.26 for the current fiscal year.

Additionally, on September 18, 2024, IDEX announced a stock repurchase program authorized by its Board of Directors, allowing the company to buy back $1.00 billion worth of shares, equivalent to 8.3% of its outstanding shares. Such initiatives often indicate that a company’s leadership views its stock as undervalued.

Dividend and Analyst Ratings

The company also declared a quarterly dividend of $0.71 per share, set to be paid on October 24, 2024, to stockholders of record as of October 10, 2024. This results in an annualized dividend of $2.84 and a dividend yield of 1.7%, with a dividend payout ratio of 45.88%.

Recent commentary from analysts has provided varied perspectives on IDEX’s stock. DA Davidson has established a price target of $180.00 with a “neutral” rating, while Oppenheimer set a target of $210.00. Citigroup has raised its target from $208.00 to $216.00 with a “buy” rating. Royal Bank of Canada revised its target down to $200.00 but maintains an “outperform” rating. Stifel Nicolaus also adjusted its target to $204.00 with a “buy” recommendation.

Currently, five analysts have rated IDEX with a “buy” rating, while two have assigned a “hold” rating. According to MarketBeat.com, the consensus rating stands at “Moderate Buy” with an average price target of $201.43.

As IDEX continues to navigate the market landscape, its recent financial strategies and institutional investments reflect a robust engagement from both investors and analysts alike.

You May Also Like

Technology

Tesla (TSLA) recently reported a year-over-year drop in second-quarter deliveries, yet the market responded with optimism, pushing the stock up by 5%. This unexpected...

Health

The All England Lawn Tennis Club in London experienced its hottest-ever opening day on Monday, as the prestigious Wimbledon tournament kicked off under unprecedented...

Technology

In a bold reimagining of the DC Universe, director James Gunn has introduced a significant narrative element in his latest film, which reveals that...

Science

Look out, daters: a new toxic relationship trend is sweeping through the romantic world, leaving many baffled and heartbroken. Known as “Banksying,” this phenomenon...

Technology

Former Speaker of the House Nancy Pelosi has recently made headlines with her latest investment in the tech sector. According to official filings, she...

Entertainment

A new documentary series titled “Animals on Drugs” is set to premiere on the Discovery Channel on July 28, 2023. The three-part series follows...

Entertainment

Netflix’s eagerly anticipated talent competition Building the Band is set to premiere on July 9, promising an emotional journey for viewers. This series, centered...

Technology

The answer to today’s NYT Wordle, dated August 8, 2025, is the verb IMBUE. This word, which means “to fill or saturate,” features three...

World

The first dose of the hepatitis B vaccine is recommended at birth, a practice that has come under scrutiny following recent comments by Health...

Sports

ZAGREB, Croatia — A concert by Marko Perkovic, a right-wing Croatian singer known for his controversial views, attracted tens of thousands of fans to...

Technology

The Evo 2025 tournament is set to take place from August 1 to August 3, 2025, showcasing some of the most popular fighting games...

Sports

As the summer of 2025 unfolds, the video game industry is set to deliver a diverse array of new releases that promise to captivate...

Politics

Billionaire hedge fund manager Bill Ackman faced significant backlash following his professional tennis debut at the Hall of Fame Open in Newport, Rhode Island,...

Lifestyle

The upcoming TRNSMT 2025 festival is set to take place from July 7 to July 9, 2025, at Glasgow Green, and organizers have released...

Business

Erin Dana Lichy, a prominent cast member of “Real Housewives of New York,” has officially settled into her dream home, a grand townhouse located...

Entertainment

While the echoes of Summer Game Fest 2025 and the Xbox Games Showcase still resonate, Xbox has already set its sights on the next...

Copyright © All rights reserved. This website provides general news and educational content for informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the information presented. The content should not be considered professional advice of any kind. Readers are encouraged to verify facts and consult appropriate experts when needed. We are not responsible for any loss or inconvenience resulting from the use of information on this site.